Loading...
XJPX4188
Market cap7.00bUSD
Dec 24, Last price  
779.10JPY
1D
0.76%
1Q
-18.35%
Jan 2017
2.78%
IPO
-4.40%
Name

Mitsubishi Chemical Group Corp

Chart & Performance

D1W1MN
XJPX:4188 chart
P/E
9.27
P/S
0.25
EPS
84.04
Div Yield, %
3.98%
Shrs. gr., 5y
0.14%
Rev. gr., 5y
2.26%
Revenues
4.39t
-5.34%
2,189,462,000,0002,408,945,000,0002,622,820,000,0002,929,810,000,0002,909,030,000,0002,515,079,000,0003,166,771,000,0003,208,168,000,0003,088,577,000,0003,498,834,000,0003,656,278,000,0003,823,098,000,0003,376,057,000,0003,724,406,000,0003,923,444,000,0003,580,510,000,0003,257,535,000,0003,976,948,000,0004,634,532,000,0004,387,218,000,000
Net income
119.60b
+23.98%
55,372,000,00085,569,000,000100,338,000,000164,064,000,000-67,178,000,00012,833,000,00083,581,000,00035,486,000,00018,596,000,00032,248,000,00060,859,000,00046,444,000,000156,259,000,000211,788,000,000169,530,000,00054,077,000,000-7,557,000,000177,162,000,00096,461,000,000119,596,000,000
CFO
465.15b
+30.96%
222,821,000,000179,723,000,00063,343,000,000156,173,000,00076,149,000,000116,073,000,000288,853,000,000217,954,000,000206,504,000,000177,027,000,000329,776,000,000388,663,000,000396,643,000,000397,940,000,000415,575,000,000452,003,000,000467,133,000,000346,871,000,000355,189,000,000465,146,000,000
Dividend
Mar 28, 20250 JPY/sh
Earnings
Feb 04, 2025

Profile

Mitsubishi Chemical Group Corporation provides performance products, chemicals, industrial gases, health care products, and other products in Japan and internationally. The company's performance products include specialty chemicals, functional food materials, inorganic materials, electronic and electrical components and products, molding and processed products, film and sheet products, synthetic paper and fiber, carbon fiber, equipment, instruments and systems, materials and products for industrial use, construction materials, civil engineering materials, aqua-related materials and products, leisure, sports, and daily goods. Its health care products comprise pharmaceuticals, pharmaceutical formulation materials and related products, drug discovery solutions, diagnostic reagents and instruments, health apparatus and instruments for medical use, medical support, nursing care and health support, and clinical examination and service. The company also offers industrial materials, such as basic chemicals, carbon materials, synthetic resins, and industrial gases; and engineering, information systems, analysis and inspection, packaging and logistics, survey, consulting, and other services. In addition, it provides engineering, transportation, and warehousing services. The company was incorporated in 2005 and is headquartered in Tokyo, Japan.
URL
https://www.mcgc.com/
IPO date
Oct 01, 2005
Employees
68,639
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
4,387,218,000
-5.34%
4,634,532,000
16.53%
3,976,948,000
22.08%
Cost of revenue
4,172,739,000
4,467,195,000
3,873,279,000
Unusual Expense (Income)
NOPBT
214,479,000
167,337,000
103,669,000
NOPBT Margin
4.89%
3.61%
2.61%
Operating Taxes
62,108,000
32,814,000
80,965,000
Tax Rate
28.96%
19.61%
78.10%
NOPAT
152,371,000
134,523,000
22,704,000
Net income
119,596,000
23.98%
96,461,000
-45.55%
177,162,000
-2,444.34%
Dividends
(44,094,000)
(42,651,000)
(38,367,000)
Dividend yield
3.25%
3.65%
3.04%
Proceeds from repurchase of equity
(33,000)
132,646,000
(27,000)
BB yield
0.00%
-11.35%
0.00%
Debt
Debt current
605,307,000
601,443,000
411,213,000
Long-term debt
1,700,033,000
1,743,412,000
1,848,321,000
Deferred revenue
260,295,000
239,168,000
Other long-term liabilities
301,775,000
39,936,000
147,212,000
Net debt
1,624,938,000
1,537,731,000
1,493,413,000
Cash flow
Cash from operating activities
465,146,000
355,189,000
346,871,000
CAPEX
(268,686,000)
(280,995,000)
(257,665,000)
Cash from investing activities
(246,087,000)
(247,632,000)
(128,781,000)
Cash from financing activities
(241,724,000)
(60,783,000)
(336,283,000)
FCF
(67,520,000)
91,944,000
(183,207,000)
Balance
Cash
294,924,000
371,693,000
296,874,000
Long term investments
385,478,000
435,431,000
469,247,000
Excess cash
461,041,100
575,397,400
567,273,600
Stockholders' equity
2,177,750,000
3,308,382,000
3,107,996,000
Invested Capital
4,317,239,900
3,927,611,600
3,788,519,400
ROIC
3.70%
3.49%
0.62%
ROCE
4.30%
3.57%
2.29%
EV
Common stock shares outstanding
1,482,796
1,486,909
1,542,643
Price
916.00
16.58%
785.70
-3.84%
817.10
-1.54%
Market cap
1,358,241,136
16.26%
1,168,264,419
-7.32%
1,260,493,558
6.94%
EV
3,495,227,136
4,555,697,419
4,511,555,558
EBITDA
489,915,000
436,953,000
355,138,000
EV/EBITDA
7.13
10.43
12.70
Interest
45,080,000
31,390,000
22,192,000
Interest/NOPBT
21.02%
18.76%
21.41%